Abcam Appoints Alan Hirzel as Chief Marketing Officer
News Jun 28, 2013
Abcam Plc. has announced that it has appointed Alan Hirzel as Chief Marketing Officer. This is a new position, based at Abcam’s Headquarters in Cambridge, UK, which will strengthen Abcam’s management team and support the company in delivering its growth strategies.
Alan will take responsibility for Abcam’s branding, product portfolio and online consumer offering. He joins Abcam on 5th August 2013.
Alan has over 20 years of global business and leadership experience. Prior to joining Abcam, he spent 14 years with leading management consultant Bain & Company, most recently serving as head of the UK Healthcare Practice and head of its London office operations.
Whilst at Bain, Alan advised a wide range of global brand executives on consumer and marketing strategies to help achieve growth targets.
Alan serves as a Trustee at The Social Business Trust, and has recently been appointed to the board of UK National Citizen Service.
Alan has a B.S. in Plant Molecular Biology and M.S. from Cornell University, and an MBA from the Johnson Graduate School of Business at Cornell.
Jonathan Milner, CEO of Abcam, commented: “We are pleased to welcome Alan to Abcam at an exciting time for the company, which sees many new growth opportunities. Alan’s life science background, and his business and leadership experience, will be of immense value to Abcam as it continues its quest to become the world-leading life science tools company.”
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.